Vallet B, Fourrier F, Hurtevent J F, Parent M, Chopin C
Service de Réanimation Polyvalente, Hôpital B, CHRU, Lille, France.
Intensive Care Med. 1992;18(7):424-6. doi: 10.1007/BF01694346.
We report a case of corticosteroid-induced myopathy with involvement of respiratory muscles observed in a myasthenic patient.
A 37-years-old woman, under corticosteroid treatment for two years for typical myasthenia gravis was admitted to ICU for acute myasthenic respiratory failure. Weaning from mechanical ventilation remained impossible despite 4 plasma exchanges and azathioprine. The patient exhibited a progressive 12 kg weight loss with muscular weakness and atrophy.
Peripheral and diaphragmatic electromyography as well as histological study were consistent with a steroid-induced myopathy. Discontinuation of corticosteroid treatment was followed by a rapid weight gain with general improvement and allowed weaning from mechanical ventilation with a complete recovery.
This case provides evidence that corticosteroid-induced myopathy may be observed in myasthenia gravis and may involve the respiratory muscles as well as the peripheral musculature.
我们报告一例在重症肌无力患者中观察到的皮质类固醇诱导性肌病累及呼吸肌的病例。
一名37岁女性,因典型重症肌无力接受皮质类固醇治疗两年,因急性重症肌无力呼吸衰竭入住重症监护病房。尽管进行了4次血浆置换和使用硫唑嘌呤,但仍无法撤机。患者体重逐渐减轻12公斤,伴有肌肉无力和萎缩。
外周和膈肌肌电图以及组织学研究均符合类固醇诱导性肌病。停用皮质类固醇治疗后,体重迅速增加,全身状况改善,得以撤机并完全康复。
该病例证明重症肌无力患者可能出现皮质类固醇诱导性肌病,且可能累及呼吸肌和外周肌肉组织。